# An Open-Label Follow-on Trial to Assess the Long-Term Safety and Efficacy of Oral SPM 927 in Subjects With Postherpetic Neuralgia (PHN)

> **NCT00238511** · PHASE2 · COMPLETED · sponsor: **UCB Pharma**

## Conditions studied

- Postherpetic Neuralgia

## Interventions

- **DRUG:** SPM 927

## Key facts

- **NCT ID:** NCT00238511
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2005-01
- **Final completion:** 2005-01
- **Target enrollment:** — (—)
- **Last updated:** 2014-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00238511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00238511, "An Open-Label Follow-on Trial to Assess the Long-Term Safety and Efficacy of Oral SPM 927 in Subjects With Postherpetic Neuralgia (PHN)". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00238511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*